JESSICA SIKAZWE: Open Payments
NPI 1518635507 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,347 in 110 payments from 42 companies in 2025. Trend: 2023 $4,388 · 2024 $3,232 · 2025 $3,347
Food & beverage: $3,247Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $307 |
| Pharmacosmos Therapeutics Inc. | 4 | $176 |
| E.R. Squibb & Sons, L.L.C. | 4 | $174 |
| GlaxoSmithKline, LLC. | 5 | $169 |
| Genmab U.S., Inc. | 3 | $159 |
| Incyte Corporation | 3 | $157 |
| Stemline Therapeutics Inc. | 4 | $156 |
| Exelixis Inc. | 3 | $145 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Myriad Genetic Laboratories, Inc. | 2 | $140 |
Products named: DARZALEX, OPDIVO, MONJUVI, Orserdu, JEMPERLI, CABOMETYX, Tivdak, MYRISK.
Industry payments across TX — which companies pay providers there.
